WHO 2026 Guidelines on Insulin Use for Adults With Type 1 Diabetes
Published: · Русский · O‘zbekcha
On November 12, 2026, WHO published updated guidelines on insulin use for adults with type 1 diabetes, including in emergency and humanitarian settings, targeting universal access by 2030.

The World Health Organization released updated evidence-based guidelines on insulin use for adults with type 1 diabetes on November 12, 2026. The guideline covers diverse health system contexts, from well-resourced facilities to emergency and humanitarian settings.
Key recommendations include: intensified insulin therapy using multiple daily injections with dose adjustments based on blood glucose monitoring is strongly recommended. Both human insulin and insulin analogues may be used; human insulin is preferred in resource-limited settings due to its lower cost.
The guideline supports WHO's global diabetes coverage target: universal access to affordable insulin treatment and blood glucose self-monitoring for all people with type 1 diabetes by 2030. It is intended for healthcare providers, programme managers, and humanitarian organizations working to deliver equitable, person-centred diabetes care.
Source: Всемирная организация здравоохранения (ВОЗ) · Read the original source ↗
Share this news




